Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
- Registry ID
- EUCTR2016-000635-40
- Source registry
- EUCTR
- Phase
- PHASE2
- Sponsor
- UCB BIOSCIENCES, Inc.
- Last update
- 2026-08-16
Conditions
Summary
The primary objective of this study is to assess the long-term safety and tolerability of rotigotine treatment in adolescents with idiopathic restless legs syndrome (RLS).
Related clinical trials
View on source registry